The local medical landscape is excited with the introduction of retatrutide, a groundbreaking dual GIP and GLP-1 medication showing impressive results in scientific trials for addressing obesity. This https://bookmarkstown.com/story22020782/the-new-retatrutide-australia-a-emerging-hope-for-weight-management